Profile | GDS5420 / 1554482_a_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 308.63 | 59 |
GSM1296119 | B_lesional_pre-dose | 1023.63 | 80 |
GSM1296076 | C_lesional_pre-dose | 838.75 | 77 |
GSM1296092 | D_lesional_pre-dose | 757.17 | 75 |
GSM1296103 | E_lesional_pre-dose | 381.6 | 63 |
GSM1296078 | F_lesional_pre-dose | 951.04 | 78 |
GSM1296107 | G_lesional_pre-dose | 843.04 | 77 |
GSM1296109 | H_lesional_pre-dose | 622.7 | 71 |
GSM1296080 | I_lesional_pre-dose | 236.89 | 56 |
GSM1296090 | J_lesional_pre-dose | 872.17 | 77 |
GSM1296074 | K_lesional_pre-dose | 1002.3 | 79 |
GSM1296111 | L_lesional_pre-dose | 1222.73 | 82 |
GSM1296099 | M_lesional_pre-dose | 564.97 | 69 |
GSM1296086 | O_lesional_pre-dose | 525.19 | 69 |
GSM1296117 | P_lesional_pre-dose | 1348.66 | 84 |
GSM1296113 | Q_lesional_pre-dose | 1134.75 | 82 |
GSM1296096 | R_lesional_pre-dose | 538.54 | 69 |
GSM1296105 | S_lesional_pre-dose | 377.93 | 62 |
GSM1296098 | T_lesional_pre-dose | 367.81 | 62 |
GSM1296101 | U_lesional_pre-dose | 293.35 | 58 |
GSM1296121 | V_lesional_pre-dose | 773.32 | 75 |
GSM1296088 | W_lesional_pre-dose | 377.46 | 63 |
GSM1296082 | X_lesional_pre-dose | 938.85 | 78 |
GSM1296115 | Y_lesional_pre-dose | 1237.86 | 83 |
GSM1296084 | Z_lesional_pre-dose | 274.53 | 58 |
GSM1296072 | B_lesional_day8 | 595.14 | 71 |
GSM1296069 | L_lesional_day8 | 966.62 | 79 |
GSM1296071 | P_lesional_day8 | 643.72 | 72 |
GSM1296070 | Y_lesional_day8 | 794.45 | 76 |
GSM1296073 | V_lesional_day8 | 1235.66 | 82 |
GSM1296034 | A_lesional_day15 | 296.84 | 58 |
GSM1296041 | G_lesional_day15 | 1159.26 | 82 |
GSM1296035 | R_lesional_day15 | 567.95 | 70 |
GSM1296038 | U_lesional_day15 | 531.62 | 69 |
GSM1296047 | B_lesional_day15 | 447.51 | 66 |
GSM1296039 | E_lesional_day15 | 1017.28 | 79 |
GSM1296042 | H_lesional_day15 | 892.78 | 78 |
GSM1296043 | L_lesional_day15 | 638.22 | 72 |
GSM1296037 | M_lesional_day15 | 243.05 | 55 |
GSM1296046 | P_lesional_day15 | 637.43 | 71 |
GSM1296044 | Q_lesional_day15 | 631.05 | 71 |
GSM1296045 | Y_lesional_day15 | 679.19 | 73 |
GSM1296025 | C_lesional_day15 | 328 | 61 |
GSM1296033 | D_lesional_day15 | 293.88 | 59 |
GSM1296027 | I_lesional_day15 | 131.54 | 48 |
GSM1296032 | J_lesional_day15 | 419.84 | 64 |
GSM1296024 | K_lesional_day15 | 293.58 | 59 |
GSM1296031 | W_lesional_day15 | 337.96 | 60 |
GSM1296028 | X_lesional_day15 | 243.99 | 56 |
GSM1296029 | Z_lesional_day15 | 286.06 | 58 |
GSM1296026 | F_lesional_day15 | 248.18 | 57 |
GSM1296030 | O_lesional_day15 | 217.9 | 55 |
GSM1296040 | S_lesional_day15 | 225.46 | 54 |
GSM1296036 | T_lesional_day15 | 462.85 | 66 |
GSM1296048 | V_lesional_day15 | 910.59 | 78 |
GSM1296059 | A_lesional_day43 | 366.76 | 62 |
GSM1296066 | G_lesional_day43 | 830.55 | 76 |
GSM1296060 | R_lesional_day43 | 427.85 | 65 |
GSM1296063 | U_lesional_day43 | 846.01 | 77 |
GSM1296064 | E_lesional_day43 | 1193.49 | 82 |
GSM1296067 | H_lesional_day43 | 314 | 58 |
GSM1296062 | M_lesional_day43 | 422.62 | 64 |
GSM1296068 | Q_lesional_day43 | 785.66 | 75 |
GSM1296050 | C_lesional_day43 | 340.89 | 62 |
GSM1296057 | D_lesional_day43 | 443.78 | 65 |
GSM1296052 | I_lesional_day43 | 133.02 | 47 |
GSM1296054 | J_lesional_day43 | 264.09 | 56 |
GSM1296049 | K_lesional_day43 | 257.13 | 57 |
GSM1296055 | W_lesional_day43 | 458.5 | 66 |
GSM1296053 | X_lesional_day43 | 227.56 | 54 |
GSM1296058 | Z_lesional_day43 | 234.13 | 55 |
GSM1296051 | F_lesional_day43 | 479.76 | 68 |
GSM1296056 | O_lesional_day43 | 678.8 | 73 |
GSM1296065 | S_lesional_day43 | 726.94 | 74 |
GSM1296061 | T_lesional_day43 | 452.66 | 65 |
GSM1296095 | A_non-lesional_pre-dose | 502.8 | 68 |
GSM1296120 | B_non-lesional_pre-dose | 673.35 | 73 |
GSM1296077 | C_non-lesional_pre-dose | 343.47 | 62 |
GSM1296093 | D_non-lesional_pre-dose | 413.04 | 64 |
GSM1296104 | E_non-lesional_pre-dose | 771.17 | 75 |
GSM1296079 | F_non-lesional_pre-dose | 215.19 | 54 |
GSM1296108 | G_non-lesional_pre-dose | 461.45 | 66 |
GSM1296110 | H_non-lesional_pre-dose | 260.45 | 55 |
GSM1296081 | I_non-lesional_pre-dose | 251.85 | 57 |
GSM1296091 | J_non-lesional_pre-dose | 326.47 | 61 |
GSM1296075 | K_non-lesional_pre-dose | 419.85 | 66 |
GSM1296112 | L_non-lesional_pre-dose | 433.43 | 64 |
GSM1296100 | M_non-lesional_pre-dose | 439.81 | 65 |
GSM1296087 | O_non-lesional_pre-dose | 130.79 | 48 |
GSM1296118 | P_non-lesional_pre-dose | 661.03 | 72 |
GSM1296114 | Q_non-lesional_pre-dose | 588.04 | 70 |
GSM1296097 | R_non-lesional_pre-dose | 388.36 | 63 |
GSM1296106 | S_non-lesional_pre-dose | 283.49 | 57 |
GSM1296102 | U_non-lesional_pre-dose | 296.48 | 58 |
GSM1296122 | V_non-lesional_pre-dose | 924.74 | 78 |
GSM1296089 | W_non-lesional_pre-dose | 222.52 | 53 |
GSM1296083 | X_non-lesional_pre-dose | 327.68 | 60 |
GSM1296116 | Y_non-lesional_pre-dose | 505.7 | 67 |
GSM1296085 | Z_non-lesional_pre-dose | 287.78 | 58 |